Table II.
Sedation, nausea, vomiting and patient satisfaction data.
| Parameter | Group TR (n=48) | Group TRSF (n=49) | Group TRF (n=50) | P-value |
|---|---|---|---|---|
| Sedation level | ||||
| 2 h | 1 (1–2) | 1 (1–2) | 1 (1–2) | 0.971 |
| 6 h | 1 (1–2) | 1 (1–2) | 1 (1–2) | 0.774 |
| 12 h | 1 (1–1) | 1 (1–1) | 1 (1–1) | 1.000 |
| 24 h | 1 (1–1) | 1 (1–1) | 1 (1–1) | 1.000 |
| 48 h | 1 (1–1) | 1 (1–1) | 1 (1–1) | 1.000 |
| Nausea severity | ||||
| 2 h | 1 (1–3) | 1 (1–3) | 1 (1–3) | 0.352 |
| 6 h | 1 (1–3) | 1 (1–3) | 1 (1–2) | 0.654 |
| 12 h | 1 (1–2) | 1 (1–2) | 1 (1–2) | 0.621 |
| 24 h | 1 (1–2) | 1 (1–2) | 1 (1–2) | 0.923 |
| 48 h | 1 (1–2) | 1 (1–2) | 1 (1–2) | 0.857 |
| Number of patients reporting vomiting, n (%) | 7 (14.5) | 9 (18.3) | 11 (22.0) | 0.638 |
| Patient satisfaction | 1 (1–3) | 1 (1–3) | 1 (1–2) | 0.502 |
Data are presented as the median (range), unless otherwise stated. Group TR, TAP block with ropivacaine; group TRSF, TAP block with ropivacaine plus subcutaneous fentanyl; group TRF, TAP block with ropivacaine-fentanyl mixture. TAP, transversus abdominis plane.